847 related articles for article (PubMed ID: 12742924)
21. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
22. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
23. Antidepressants for depressed elderly.
Mottram P; Wilson K; Strobl J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003491. PubMed ID: 16437456
[TBL] [Abstract][Full Text] [Related]
24. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
25. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
26. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
J Clin Psychiatry; 2008 Sep; 69(9):1404-15. PubMed ID: 19193341
[TBL] [Abstract][Full Text] [Related]
27. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
28. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
KoKoAung E; Cavenett S; McArthur A; Aromataris E
JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
30. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.
Barbui C; Hotopf M
Br J Psychiatry; 2001 Feb; 178():129-44. PubMed ID: 11157426
[TBL] [Abstract][Full Text] [Related]
31. [Mirtazapine versus other antidepressive agents for depression].
Knud Larsen J
Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
[TBL] [Abstract][Full Text] [Related]
32. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Apr; (4):CD006117. PubMed ID: 20393946
[TBL] [Abstract][Full Text] [Related]
33. Fluvoxamine versus other anti-depressive agents for depression.
Omori IM; Watanabe N; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2010 Mar; (3):CD006114. PubMed ID: 20238342
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of antidepressants in Parkinson's disease: A systematic review and network meta-analysis.
Mills KA; Greene MC; Dezube R; Goodson C; Karmarkar T; Pontone GM
Int J Geriatr Psychiatry; 2018 Apr; 33(4):642-651. PubMed ID: 29235150
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
36. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
37. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
38. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
Martin RM; Hilton SR; Kerry SM; Richards NM
BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479
[TBL] [Abstract][Full Text] [Related]
39. Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
Cipriani A; Furukawa TA; Geddes JR; Malvini L; Signoretti A; McGuire H; Churchill R; Nakagawa A; Barbui C;
J Clin Psychiatry; 2008 Nov; 69(11):1732-42. PubMed ID: 19026250
[TBL] [Abstract][Full Text] [Related]
40. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
